| 93418-2 |
(8;8)(q13;q21)(HEY1,NCOA2) fusion transcript |
PrThr |
Tiss |
Pt |
Ord |
Molgen |
|
ACTIVE |
(8;8)(q13;q21)(HEY1,NCOA2) fusion transcript [Presence] in Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
93418-2 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
(8;8)(HEY1,NCOA2) Tiss Ql |
|
|
|
|
|
(8;8)(HEY1,NCOA2); DNA; gene fusion; gene translocation; Molecular genetics; Molecular pathology; MOLPATH; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; RNA; Screen; Tissue; Tissue, unspecified; translocation |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
|
| 98203-3 |
(Diffusion capacity/Alveolar volume)/predicted |
RelInvVI |
Respiratory system |
Pt |
Qn |
|
|
ACTIVE |
(Diffusion capacity/Alveolar volume)/predicted |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
PULM |
|
98203-3 |
|
|
|
|
Both |
|
|
|
0 |
(Diff cap/Alv vol)/predicted |
|
|
|
N |
|
(Diff cap; (Diff cap/Alv vol)/predicted; ALV; Breathing; Diff cap; DL; Lung; Lungs; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Vol |
2.71 |
2.71 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
|
| 32406-1 |
Color^1M post birth |
Fcn |
^Patient |
Pt |
Ord |
Apgar |
|
ACTIVE |
1 minute Apgar Color |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
NEONAT |
|
32406-1 |
|
Apgar |
|
|
Observation |
|
|
|
0 |
1M Apgar Color |
|
|
|
N |
|
After; Appearance; Colour; Function; Gyn; Gynecology; NEONAT; OB; ObGyn; Obstetrics; Ordinal; p birth; Point in time; PST; QL; Qual; Qualitative; Random; Screen |
2.36 |
2.07 |
|
|
|
|
|
|
|
|
|
|
|
0 |
|
| 32407-9 |
Heart rate^1M post birth |
Fcn |
^Patient |
Pt |
Ord |
Apgar |
|
ACTIVE |
1 minute Apgar Heart rate |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
NEONAT |
|
32407-9 |
|
Apgar |
|
|
Observation |
|
|
|
0 |
1M Apgar Heart rate |
|
|
|
N |
|
After; Function; Gyn; Gynecology; Heart beat; NEONAT; OB; ObGyn; Obstetrics; Ordinal; p birth; Point in time; PST; Pulse; QL; Qual; Qualitative; Random; Screen |
2.36 |
2.07 |
|
|
|
|
|
|
|
|
|
|
|
0 |
|
| 32408-7 |
Muscle tone^1M post birth |
Fcn |
^Patient |
Pt |
Ord |
Apgar |
|
ACTIVE |
1 minute Apgar Muscle tone |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
NEONAT |
|
32408-7 |
|
Apgar |
|
|
Observation |
|
|
|
0 |
1M Apgar Muscle tone |
|
|
|
N |
|
Activity; After; Function; Gyn; Gynecology; Musc; Muscl; NEONAT; OB; ObGyn; Obstetrics; Ordinal; p birth; Point in time; PST; QL; Qual; Qualitative; Random; Screen |
2.36 |
2.07 |
|
|
|
|
|
|
|
|
|
|
|
0 |
|
| 32409-5 |
Reflex irritability^1M post birth |
Fcn |
^Patient |
Pt |
Ord |
Apgar |
|
ACTIVE |
1 minute Apgar Reflex irritability |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
NEONAT |
|
32409-5 |
|
Apgar |
|
|
Observation |
|
|
|
0 |
1M Apgar Reflex irritability |
|
|
|
N |
|
After; Function; Grimace; Gyn; Gynecology; NEONAT; OB; ObGyn; Obstetrics; Ordinal; p birth; Point in time; PST; QL; Qual; Qualitative; Random; Screen |
2.36 |
2.07 |
|
|
|
|
|
|
|
|
|
|
|
0 |
|
| 32410-3 |
Respiratory effort^1M post birth |
Fcn |
^Patient |
Pt |
Ord |
Apgar |
|
ACTIVE |
1 minute Apgar Respiratory effort |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
NEONAT |
|
32410-3 |
|
Apgar |
|
|
Observation |
|
|
|
0 |
1M Apgar Resp effort |
|
|
|
N |
|
After; Function; Gyn; Gynecology; NEONAT; OB; ObGyn; Obstetrics; Ordinal; p birth; Point in time; PST; QL; Qual; Qualitative; Random; Resp effort; Screen |
2.36 |
2.07 |
|
|
|
|
|
|
|
|
|
|
|
0 |
|
| 9272-6 |
Score^1M post birth |
Fcn |
^Patient |
Pt |
Qn |
Apgar |
|
ACTIVE |
1 minute Apgar Score |
|
MIN |
DefinitionDescription |
|
|
score |
|
|
|
|
|
|
NEONAT |
|
9272-6 |
|
Apgar |
|
|
Observation |
|
|
|
0 |
1M Apgar Score |
|
|
|
|
|
After; Function; Gyn; Gynecology; NEONAT; OB; ObGyn; Obstetrics; p birth; Point in time; PST; QNT; Quan; Quant; Quantitative; Random |
2.73 |
1.0i |
|
|
|
|
|
|
|
{score} |
|
|
We made an administrative decision to define the total scores from arious survey instruments as Quantitative rather than ordinal. There is no intention to change the existing meaning |
0 |
|
| 48334-7 |
Apgar panel^1M post birth |
- |
^Patient |
Pt |
- |
Apgar |
|
ACTIVE |
1 minute Apgar panel |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.NEONAT |
|
48334-7 |
|
Apgar |
|
|
Order |
|
|
|
0 |
1M Apgar Pnl |
|
|
|
N |
|
After; Apgar Pnl; Gyn; Gynecology; NEONAT; OB; ObGyn; Obstetrics; p birth; Pan; PANEL.NEONAT; Panl; Pnl; Point in time; PST; Random |
2.63 |
2.21 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
|
| 89421-2 |
1 step (curb) - functional ability |
Find |
^Patient |
Pt |
Ord |
CMS Assessment |
|
ACTIVE |
1 step (curb) - functional ability [CMS Assessment] |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CMS |
|
89421-2 |
|
CMS Assessment |
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; i; IADL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
|
| 83196-6 |
1 step (curb) - functional ability during 3D assessment period |
Find |
^Patient |
3D |
Ord |
CMS Assessment |
|
ACTIVE |
1 step (curb) - functional ability during 3 day assessment period [CMS Assessment] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CMS |
|
83196-6 |
|
CMS Assessment |
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
1 step curb ability; 3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; i; Ordinal; Ql; Qual; Qualitative; Screen; Survey |
2.64 |
2.61 |
|
|
|
|
|
|
|
|
|
|
|
0 |
|
| 83195-8 |
1 step (curb) - functional goal recorded during 3D assessment period |
Find |
^Patient |
3D |
Ord |
CMS Assessment |
|
ACTIVE |
1 step (curb) - functional goal during 3 day assessment period [CMS Assessment] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CMS |
|
83195-8 |
|
CMS Assessment |
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
1 step curb goal; 3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; i; Ordinal; Ql; Qual; Qualitative; Screen; Survey |
2.64 |
2.61 |
|
|
|
|
|
|
|
|
|
|
|
0 |
|
| 80628-1 |
1,1'-Sulfonylbis-2-Methylthioethane |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
1,1'-Sulfonylbis-2-Methylthioethane [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
80628-1 |
|
|
|
|
Both |
|
|
|
0 |
SBMTE Ur-mCnc |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Esoteric; i; II; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; SBMTE; Sulfur mustard gas metabolite; UA; UR; Urn |
2.56 |
2.56 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
|
| 38624-3 |
1,1,2-Trichloroethane |
MCnc |
Air |
Pt |
Qn |
|
|
ACTIVE |
1,1,2-Trichloroethane [Mass/volume] in Air |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
38624-3 |
|
|
|
|
Observation |
|
|
|
0 |
1,1,2TCE Air-mCnc |
|
|
|
N |
|
1,1,1-TCE; 1,1,2TCE; 1,1,2-TCE; Aerothene tt; Alpha trichloroethane; Beta trichloroethane; Beta-T; C2H3Cl3; Chlorothene; Chlorothene NU; Chlorothene VG; DRUG/TOXICOLOGY; Drugs; i; II; Level; Mass concentration; Methyl chloroform; Methylchloroform; Methyltrichloromethane; Point in time; QNT; Quan; Quant; Quantitative; Random; TCE; Tri-ethane; Vinyl trichloride |
2.34 |
2.14 |
|
|
|
|
|
|
|
|
|
|
|
0 |
|
| 38334-9 |
1,1,2-Trichloroethane |
MCnc |
Water |
Pt |
Qn |
|
|
ACTIVE |
1,1,2-Trichloroethane [Mass/volume] in Water |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
38334-9 |
|
|
|
|
Observation |
|
|
|
0 |
1,1,2TCE Wat-mCnc |
|
|
|
N |
|
1,1,1-TCE; 1,1,2TCE; 1,1,2-TCE; Aerothene tt; Alpha trichloroethane; Beta trichloroethane; Beta-T; C2H3Cl3; Chlorothene; Chlorothene NU; Chlorothene VG; DRUG/TOXICOLOGY; Drugs; i; II; Level; Mass concentration; Methyl chloroform; Methylchloroform; Methyltrichloromethane; Point in time; QNT; Quan; Quant; Quantitative; Random; TCE; Tri-ethane; Vinyl trichloride; Wat |
2.34 |
2.13 |
|
|
|
|
|
|
|
|
|
|
|
0 |
|
| 38699-5 |
1,1-Dichloroethane |
MCnc |
Air |
Pt |
Qn |
|
|
ACTIVE |
1,1-Dichloroethane [Mass/volume] in Air |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
38699-5 |
|
|
|
|
Both |
|
|
|
0 |
1,1-DCA Air-mCnc |
|
|
|
N |
|
1,1-DCA; 1,1-dichlorethane; DCA; DRUG/TOXICOLOGY; Drugs; Ethylidene chloride; Ethylidene dichloride; i; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.34 |
2.14 |
|
|
|
|
|
|
|
|
|
|
|
0 |
|
| 38735-7 |
1,1-Dichloroethylene |
MCnc |
Air |
Pt |
Qn |
|
|
ACTIVE |
1,1-Dichloroethylene [Mass/volume] in Air |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
38735-7 |
|
|
|
|
Observation |
|
|
|
0 |
1,1-DCE Air-mCnc |
|
|
|
N |
|
1,1-DCE; 1,1-Dichloroethene; Asym-dichloro-ethylene; DCE; DRUG/TOXICOLOGY; Drugs; i; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Vinylidene; Vinylidine |
2.34 |
2.14 |
|
|
|
|
|
|
|
|
|
|
|
0 |
|
| 38292-9 |
1,1-Dichloroethylene |
MCnc |
Water |
Pt |
Qn |
|
|
ACTIVE |
1,1-Dichloroethylene [Mass/volume] in Water |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
38292-9 |
|
|
|
|
Observation |
|
|
|
0 |
1,1-DCE Wat-mCnc |
|
|
|
N |
|
1,1-DCE; 1,1-Dichloroethene; Asym-dichloro-ethylene; DCE; DRUG/TOXICOLOGY; Drugs; i; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Vinylidene; Vinylidine; Wat |
2.34 |
2.13 |
|
|
|
|
|
|
|
|
|
|
|
0 |
|
| 74622-2 |
1,1-Dimethoxy-(9Z)octadecene |
MCnt |
Fibroblasts |
Pt |
Qn |
|
|
ACTIVE |
1,1-Dimethoxy-(9Z)octadecene (DMA 18:1) [Mass/mass] in Fibroblast |
|
MIN |
DefinitionDescription |
|
|
ug/mg protein |
|
|
|
|
|
|
CHEM |
|
74622-2 |
|
|
|
|
Both |
|
|
|
0 |
DMA 18:1 Fib-mCnt |
|
|
|
|
|
Chemistry; dimethyl acetal oleic; DMA 18:1; DMA C18:1; Fib; Fibr; i; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.48 |
2.48 |
|
|
|
|
|
|
|
ug/mg{protein} |
|
|
|
0 |
|
| 74623-0 |
1,1-Dimethoxy-(9Z)octadecene |
SCnt |
RBC |
Pt |
Qn |
|
|
ACTIVE |
1,1-Dimethoxy-(9Z)octadecene (DMA 18:1) [Moles/mass] in Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
nmol/100mg Hb |
|
|
|
|
|
|
CHEM |
|
74623-0 |
|
|
|
|
Both |
|
|
|
0 |
DMA 18:1 RBC-sCnt |
|
|
|
|
|
Chemistry; dimethyl acetal oleic; DMA 18:1; DMA C18:1; Erythrocytes; i; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Substance content |
2.66 |
2.48 |
|
|
|
|
|
|
|
nmol/(100.mg){Hb} |
|
|
|
0 |
|
| 74620-6 |
1,1-Dimethoxy-(9Z)octadecene/oleate |
MRto |
Fibroblasts |
Pt |
Qn |
|
|
ACTIVE |
1,1-Dimethoxy-(9Z)octadecene (DMA 18:1)/Oleate (C18:1w9) [Mass Ratio] in Fibroblast |
|
MIN |
DefinitionDescription |
|
|
ratio |
|
|
|
|
|
|
CHEM |
|
74620-6 |
|
|
|
|
Both |
|
|
|
0 |
DMA 18:1/Oleate Fib |
|
|
|
|
|
C18:1w9; Chemistry; dimethyl acetal oleic; DMA 18:1; DMA C18:1; Fib; Fibr; i; Mass concentration ratio; Mass ratio; MCRto; Oleic acid; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.48 |
2.48 |
|
|
|
|
|
|
|
{ratio} |
|
|
|
0 |
|
| 74621-4 |
1,1-Dimethoxy-(9Z)octadecene/oleate |
SRto |
RBC |
Pt |
Qn |
|
|
ACTIVE |
1,1-Dimethoxy-(9Z)octadecene (DMA 18:1)/Oleate (C18:1w9) [Molar ratio] in Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
ratio |
|
|
|
|
|
|
CHEM |
|
74621-4 |
|
|
|
|
Both |
|
|
|
0 |
DMA 18:1/Oleate RBC-sRto |
|
|
|
|
|
C18:1w9; Chemistry; dimethyl acetal oleic; DMA 18:1; DMA C18:1; Erythrocytes; i; Oleic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Scrto; Substance concentration ratio; Substance ratio |
2.48 |
2.48 |
|
|
|
|
|
|
|
{ratio} |
|
|
|
0 |
|
| 74626-3 |
1,1-Dimethoxyhexadecane |
MCnt |
Fibroblasts |
Pt |
Qn |
|
|
ACTIVE |
1,1-Dimethoxyhexadecane (DMA 16:0) [Mass/mass] in Fibroblast |
|
MIN |
DefinitionDescription |
|
|
ug/mg protein |
|
|
|
|
|
|
CHEM |
|
74626-3 |
|
|
|
|
Both |
|
|
|
0 |
DMA 16:0 Fib-mCnt |
|
|
|
|
|
Chemistry; dimethyl acetal palmitic; DMA 16:0; DMA C16:0; Fib; Fibr; i; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.48 |
2.48 |
|
|
|
|
|
|
|
ug/mg{protein} |
|
|
|
0 |
|
| 74627-1 |
1,1-Dimethoxyhexadecane |
SCnt |
RBC |
Pt |
Qn |
|
|
ACTIVE |
1,1-Dimethoxyhexadecane (DMA 16:0) [Moles/mass] in Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
nmol/100mg Hb |
|
|
|
|
|
|
CHEM |
|
74627-1 |
|
|
|
|
Both |
|
|
|
0 |
DMA 16:0 RBC-sCnt |
|
|
|
|
|
Chemistry; dimethyl acetal palmitic; DMA 16:0; DMA C16:0; Erythrocytes; i; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Substance content |
2.66 |
2.48 |
|
|
|
|
|
|
|
nmol/(100.mg){Hb} |
|
|
|
0 |
|
| 74624-8 |
1,1-Dimethoxyhexadecane/palmitate |
MRto |
Fibroblasts |
Pt |
Qn |
|
|
ACTIVE |
1,1-Dimethoxyhexadecane (DMA 16:0)/palmitate (C16:0) [Mass Ratio] in Fibroblast |
|
MIN |
DefinitionDescription |
|
|
ratio |
|
|
|
|
|
|
CHEM |
|
74624-8 |
|
|
|
|
Both |
|
|
|
0 |
DMA 16:0/C16:0 Fib |
|
|
|
|
|
C16:0; Chemistry; dimethyl acetal palmitic; DMA 16:0; DMA C16:0; Fib; Fibr; Hexadecanoate; Hexadecanoic acid; i; Mass concentration ratio; Mass ratio; MCRto; Palmitic acid; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.48 |
2.48 |
|
|
|
|
|
|
|
{ratio} |
|
|
|
0 |
|
